Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer

NCT02360059 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Breast Cancer

Interventions

DRUG: Metformin
OTHER: Placebo
BEHAVIORAL: Questionnaires
OTHER: Sensory and Fine-Motor Tests

Sponsor

M.D. Anderson Cancer Center